Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

NeuroBo (NRBO) Stock Soars 125% on Reverse Stock Split News

Most of the time, a reverse stock split is bad news. But for investors in NeuroBo and NRBO stock today, this news is being cheered.

Why Is InMed (INM) Stock Up 60% Today?

Today, investors in InMed and INM stock are cheering a capital raise announced on Friday as well as other R&D updates shared last week.

What Is Going on With Spectrum Pharmaceuticals (SPPI) Stock Today?

Spectrum Pharmaceuticals received regulatory approval for its oncology-related infection-reducing therapeutic, bolstering SPPI stock.

AMC Stock Pops as Adam Aron Touts Disney+ Collaboration

AMC Entertainment is teaming up with Disney+ to help consumers enjoy more movies. Here's why this news is good for both DIS and AMC stock.

What Is Going on With Roblox (RBLX) Stock Today?

RBLX stock is in focus following an announcement that the company will debut immersive 3D ads next year and an initiation by Cowen.

Why Is Ra Medical Systems (RMED) Stock Up 30% Today?

RA Medical Devices is on the verge of acquiring Catheter Precision. Here's why RMED stock is up and why this is a good deal for both.

Huobi Global De-Listing Privacy Coins Amid Regulator Crackdown

Huobi Global, seeking expansion to the U.S. market, is making moves implied to better its chances of achieving government approval.

ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week

We're starting off another week with a deep dive into the short squeeze stocks traders are going to want to keep an eye on!

ASTS Stock: What to Know as AST SpaceMobile’s BlueWalker 3 Reaches Orbit

AST SpaceMobile (ASTS) stock is in the news Monday as the company's BlueWalker 3 satellite entered Earth's orbit over the weekend.

GOOG Stock: What to Know About Alphabet’s Secret Telecom Project Aalyria

GOOG stock isn't moving much today, but don't be fooled -- Alphabet has a mysterious spinoff in the works that could be a game-changer.

NVTA Stock Alert: Invitae Announces Data-Sharing Partnership With Simons Searchlight

Shares of NVTA stock are in focus after the company announced a data-sharing collaboration with Simons Searchlight.

Why One Analyst Says Carvana (CVNA) Stock Is ‘Grossly Undervalued’

Could CVNA stock be turning a corner today? It's possible as a Wall Street expert contends that "substantial upside" may be in store.

Solana Price Predictions: What’s Next for the Red-Hot SOL Crypto?

Solana (SOL) price predictions are a hot topic for Monday as investors react to the crypto trending on social media and other platforms.

Why Is Ventyx Biosciences (VTYX) Stock Up 70% Today?

Ventyx Biosciences (VTYX) stock is rocketing higher on Monday after Oppenheimer analyst Jeff Jones provided an update on the shares.

QSR Stock Pops as Burger Kings Announces $400 Million Investment

Restaurant Brands International (QSR) stock is gaining on Monday after Burger King announced plans to invest $400 million into its business.

Warren Buffett Keeps Buying Occidental Petroleum (OXY) Stock

OXY stock gives Berkshire Hathaway a low cost for the natural gas its utilities need, and its debt is also valuable.

Adobe (ADBE) Stock Slips on Analyst Downgrade

Adobe (ADBE) stock is sliding lower on Monday after the software company was hit with a downgrade from Mizuho analyst Gregg Moskowitz.

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

Sotyktu's Phase 3 study showed it more effective than Amgen's Otezla for treating psoriasis.

Why Is Clovis Oncology (CLVS) Stock Up 11% Today?

Clovis Oncology (CLVS) stock is rising higher on Monday following the release of results from a Phase 3 ovarian cancer clinical trial.